COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1832: Articles 18311-18320  | Next

Modeling the population effects of epitope specific escape mutations in SARS-CoV-2 to guide vaccination strategies
Koopman, J. S., Simon, C. P., Getz, W. M., Salter, R.
10.1101/2021.01.19.21250114 — Posted: 2021-01-20
A Label-Free SARS-CoV-2 Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients
Luo, Y. R., Yun, C., Chakraborty, I., Wu, A. H. B., Lynch, K. L.
10.1101/2021.01.19.21250137 — Posted: 2021-01-20
Overcrowding and Exposure to Secondhand Smoke Increase Risk for COVID-19 Infection Among Latinx Families in Greater San Francisco Bay Area
DeCastro Mendez, A., Escobar, M., Romero Encinas, M., Wojcicki, J.
10.1101/2021.01.19.21250139 — Posted: 2021-01-20
Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19
Syed, F., Li, W., Relich, R. F., Russell, P. M., Zhang, S., Zimmerman, M. K., Yu, Q.
10.1101/2021.01.19.21250115 — Posted: 2021-01-20
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
Rathnasinghe, R., Jangra, S., Cupic, A., Martinez-Romero, C., Mulder, L. C. F., Kehrer, T., Yildiz, S., Choi, A., Mena, I., De Vrieze, J., Aslam, S., Stadlbauer, D., Meekins, D. A., McDowell, C. D., Balaraman, V., Richt, J. A., De Geest, B. G., Miorin, L., Personalized Virology Initiative, , Krammer, F., Simon, V., Garcia-Sastre, A., Schotsaert, M.
10.1101/2021.01.19.21249592 — Posted: 2021-01-20 Discussion: Onsite
Head-to-head comparison of direct-input RT-PCR and RT-LAMP against RTqPCR on extracted RNA for rapid SARS-CoV-2 diagnostics
Kellner, M. J., Matl, M., Ross, J. J., Schnabl, J., Handler, D., Heinen, R., Schaeffer, J., Hufnagl, P., Indra, A., Dekens, M., Fritsche-Polanz, R., Foedinger, M., Zuber, J., Allerberger, F., Pauli, A., Brennecke, J.
10.1101/2021.01.19.21250079 — Posted: 2021-01-20
Deficient hand washing facilities in public toilets in the time of the COVID-19 pandemic: A survey in one high-income country
Wilson, N., Thomson, G.
10.1101/2021.01.19.21250124 — Posted: 2021-01-20
Sleep in Frontline Healthcare Workers on Social Media During the COVID-19 Pandemic
Stewart, N. H., Koza, A. L., Dhaon, S., Shoushtari, C., Martinez, M., Arora, V. M.
10.1101/2021.01.19.21250128 — Posted: 2021-01-20
Exploring overcrowding trends in an inner city emergence department in the UK before and during COVID-19 epidemic
Panovska-Griffiths, J., Ross, J., Elkhodair, S., Baxter-Derrington, C., Laing, C., Raine, R.
10.1101/2021.01.20.21250150 — Posted: 2021-01-20
GRP78 binds SARS-CoV-2 Spike protein and ACE2 and GRP78 depleting antibody blocks viral entry and infection in vitro
Carlos, A. J., Ha, D. P., Yeh, D.-W., Van Krieken, R., Gill, P., Machida, K., Lee, A.
10.1101/2021.01.20.427368 — Posted: 2021-01-20 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).